UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 245

Sortiert nach

Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms

Nature communications, 2019-01, Vol.10 (1), p.244-13, Article 244

2019

Volltextzugriff (PDF)

Role of Oatp2b1 in Drug Absorption and Drug-Drug Interactions

Drug metabolism and disposition, 2020-05, Vol.48 (5), p.419-426

2020

Volltextzugriff (PDF)

Differential Metabolism of Gefitinib and Erlotinib by Human Cytochrome P450 Enzymes

Clinical cancer research, 2007-06, Vol.13 (12), p.3731-3737

2007

Volltextzugriff (PDF)

Crenolanib is active against models of drug-resistant FLT3-ITD−positive acute myeloid leukemia

Blood, 2013-11, Vol.122 (22), p.3607-3615

2013

Volltextzugriff (PDF)

In memoriam Michelle A. Rudek (1972–2023)

Clinical and translational science, 2024-01, Vol.17 (1), p.e13705-n/a

2024

Volltextzugriff (PDF)

Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide

Clinical cancer research, 2013-03, Vol.19 (6), p.1458-1466

2013

Volltextzugriff (PDF)

Targeting OCT3 attenuates doxorubicin-induced cardiac injury

Proceedings of the National Academy of Sciences - PNAS, 2021-02, Vol.118 (5)

2021

Volltextzugriff (PDF)

A phosphotyrosine switch regulates organic cation transporters

Nature communications, 2016-03, Vol.7 (1), p.10880-10880, Article 10880

2016

Volltextzugriff (PDF)

Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice

Nature communications, 2023-06, Vol.14 (1), p.3175-3175, Article 3175

2023

Volltextzugriff (PDF)

Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51

PloS one, 2013-11, Vol.8 (11), p.e79106

2013

Volltextzugriff (PDF)

Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibition

Kidney international, 2021-12, Vol.100 (6), p.1214-1226

2021

Volltextzugriff (PDF)

Hepatocellular Shuttling and Recirculation of Sorafenib-Glucuronide Is Dependent on Abcc2, Abcc3, and Oatp1a/1b

Cancer research (Chicago, Ill.), 2015-07, Vol.75 (13), p.2729-2736

2015

Volltextzugriff (PDF)

Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B

Molecules (Basel, Switzerland), 2022-10, Vol.27 (20), p.6815

2022

Volltextzugriff (PDF)

Phase I Pharmacokinetic and Pharmacodynamic Study of the Multikinase Inhibitor Sorafenib in Combination With Clofarabine and Cytarabine in Pediatric Relapsed/Refractory Leukemia

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3293-3300

2011

Volltextzugriff (PDF)

Castration-Dependent Pharmacokinetics of Docetaxel in Patients With Prostate Cancer

Journal of clinical oncology, 2010-10, Vol.28 (30), p.4562-4567

2010

Volltextzugriff (PDF)

Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors

Pharmaceutics, 2020-09, Vol.12 (9), p.856

2020

Volltextzugriff (PDF)

DNA methyltransferase inhibitor exposure–response: Challenges and opportunities

Clinical and translational science, 2023-08, Vol.16 (8), p.1309-1322

2023

Volltextzugriff (PDF)

Interaction of Imatinib with Human Organic Ion Carriers

Clinical cancer research, 2008-05, Vol.14 (10), p.3141-3148

2008

Volltextzugriff (PDF)

Interaction of the Multikinase Inhibitors Sorafenib and Sunitinib with Solute Carriers and ATP-Binding Cassette Transporters

Clinical cancer research, 2009-10, Vol.15 (19), p.6062-6069

2009

Volltextzugriff (PDF)

A kinome-wide screen identifies a CDKL5-SOX9 regulatory axis in epithelial cell death and kidney injury

Nature communications, 2020-04, Vol.11 (1), p.1924-15, Article 1924

2020

Volltextzugriff (PDF)

Author Correction: Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice

Nature communications, 2023-06, Vol.14 (1), p.3335-3335, Article 3335

2023

Volltextzugriff (PDF)

Pharmacogenetics of ABCG2 and Adverse Reactions to Gefitinib

JNCI : Journal of the National Cancer Institute, 2006-12, Vol.98 (23), p.1739-1742

2006

Volltextzugriff (PDF)

A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML

Nature communications, 2019-05, Vol.10 (1), p.2189-16, Article 2189

2019

Volltextzugriff (PDF)

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion

Cancers, 2022-12, Vol.15 (1), p.29

2022

Volltextzugriff (PDF)

Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death

Cancer research (Chicago, Ill.), 2016-01, Vol.76 (1), p.117-126

2016

Volltextzugriff (PDF)

1 – 25 von 245

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(242)
Mit Volltextzugriff
(238)

Publikationsform

Artikel
(243)
Buchkapitel
(2)

Sprache

Englisch
(245)
Japanisch
(44)

Erscheinungsjahr

n.n

Thema

Science & Technology
(178)
Life Sciences & Biomedicine
(169)
Humans
(163)
Oncology
(112)
Female
(93)
Biological And Medical Sciences
(88)
Medical Sciences
(87)
Male
(85)
Pharmacology. Drug Treatments
(74)
Middle Aged
(65)
Adult
(64)
Aged
(61)
Antineoplastic Agents
(61)
Animals
(50)
Chemotherapy
(49)
Neoplasms - Drug Therapy
(47)
Mice
(40)
Pharmacokinetics
(39)
Pharmacology & Pharmacy
(38)
Antineoplastic Agents - Pharmacokinetics
(34)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms

Role of Oatp2b1 in Drug Absorption and Drug-Drug Interactions

Differential Metabolism of Gefitinib and Erlotinib by Human Cytochrome P450 Enzymes

Crenolanib is active against models of drug-resistant FLT3-ITD−positive acute myeloid leukemia

In memoriam Michelle A. Rudek (1972–2023)

Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide

Targeting OCT3 attenuates doxorubicin-induced cardiac injury

A phosphotyrosine switch regulates organic cation transporters

Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice

Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51

Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibition

Hepatocellular Shuttling and Recirculation of Sorafenib-Glucuronide Is Dependent on Abcc2, Abcc3, and Oatp1a/1b

Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B

Phase I Pharmacokinetic and Pharmacodynamic Study of the Multikinase Inhibitor Sorafenib in Combination With Clofarabine and Cytarabine in Pediatric Relapsed/Refractory Leukemia

Castration-Dependent Pharmacokinetics of Docetaxel in Patients With Prostate Cancer

Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors

DNA methyltransferase inhibitor exposure–response: Challenges and opportunities

Interaction of Imatinib with Human Organic Ion Carriers

Interaction of the Multikinase Inhibitors Sorafenib and Sunitinib with Solute Carriers and ATP-Binding Cassette Transporters

A kinome-wide screen identifies a CDKL5-SOX9 regulatory axis in epithelial cell death and kidney injury

Author Correction: Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice

Pharmacogenetics of ABCG2 and Adverse Reactions to Gefitinib

A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion

Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death

Aktive Filter

Suchergebnisse filtern